Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Financing Activities (2016 - 2025)

ENDRA Life Sciences has reported Cash from Financing Activities over the past 6 years, most recently at $321076.0 for Q4 2021.

  • Quarterly Cash from Financing Activities fell 94.24% to $321076.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $13.4 million through Dec 2021, up 12.86% year-over-year, with the annual reading at $5.7 million for FY2025, 26.59% down from the prior year.
  • Cash from Financing Activities was $321076.0 for Q4 2021 at ENDRA Life Sciences, down from $496606.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $12.6 million in Q1 2021 and troughed at $39238.0 in Q1 2020.
  • The 5-year median for Cash from Financing Activities is $2.5 million (2019), against an average of $3.9 million.
  • The largest YoY upside for Cash from Financing Activities was 31970.75% in 2021 against a maximum downside of 94.24% in 2021.
  • A 5-year view of Cash from Financing Activities shows it stood at $8.5 million in 2017, then decreased by 9.41% to $7.7 million in 2018, then decreased by 24.45% to $5.8 million in 2019, then fell by 4.67% to $5.6 million in 2020, then tumbled by 94.24% to $321076.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Cash from Financing Activities are $321076.0 (Q4 2021), $496606.0 (Q3 2021), and $12.6 million (Q1 2021).